• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 418563 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1414678642 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1414678642 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Hot Stock: Idenix Pharmaceuticals, Shares Drop 5.2% (IDIX)

Published on Wed, 01/09/2013 - 13:22
By Robert Cotter

Idenix Pharmaceuticals (NASDAQ:IDIX) is one of today's worst performing low-priced stocks, down 5.2% to $4.80 on 1.8x average daily volume. Thus far today, Idenix Pharmaceuticals has traded 1.8 million shares, vs. average volume of 983,000 shares per day. The stock has underperformed the Dow (-5.2% to the Dow's 0.4%) and underperformed the S&P 500 (-5.2% to the S&P's 0.2%) during today's trading.

Idenix Pharmaceuticals Inc. is a biopharmaceutical company that discovers and develops drugs for the treatment of human viral and other infectious diseases. The Company is focusing on the treatment of infections caused by hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV).

Idenix Pharmaceuticals (NASDAQ:IDIX) has potential upside of 37.6% based on a current price of $4.79 and analysts' consensus price target of $6.60. The stock should find resistance at its 200-day moving average (MA) of $7.09, as well as support at its 50-day MA of $4.69.

In the past 52 weeks, shares of Idenix Pharmaceuticals have traded between a low of $3.35 and a high of $15.25 and are now at $4.79, which is 43% above that low price. The 200-day and 50-day moving averages have moved 1.14% lower and 1.55% higher over the past week, respectively.

By Robert Cotter
rcotter@fnno.com

Latest News from FNNO

Next Support Level for Ford Motor (F) is...

Shares of Ford Motor (NYSE:F) opened today below their pivot of $13.95 and have already ...

Clicksoftware Technologies Defies the Ra...

A week ago, Lake Street downgraded Clicksoftware Technologies from Buy to Hold. Clicks ...

Citrix Systems Down 2.7% Since Drexel Ha...

One week ago Citrix Systems (NASDAQ:CTXS) was downgraded from Buy to Hold at Drexel Ham ...

Pan American Silver Down 0.4% Since Raym...

Pan American Silver was upgraded from Market Perform to Outperform by Raymond James one ...

Analyst Rating Flashback: ICON Down 5.6%...

A week ago, First Analysis downgraded ICON from Overweight to Equal Weight. The shares ...

Tractor Supply Fulfills the Promise: Up ...

One week ago Tractor Supply (NASDAQ:TSCO) was upgraded from Market Perform to Strong Bu ...

Melco Crown Entertainment Up 2.2% Since ...

One week ago Melco Crown Entertainment (NASDAQ:MPEL) was downgraded from Buy to Neutral ...

Oracle Up 2.5% Since Tigress Financial D...

Oracle was downgraded from Buy to Neutral by Tigress Financial one week ago. Oracle st ...